Myeloid Differentiation Primary Response Protein MyD88 (MYD88) Peptide
175.5€ (100 µg)
Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.
935106861
info@markelab.com
name
Myeloid Differentiation Primary Response Protein MyD88 (MYD88) Peptide
category
Proteins and Peptides
provider
Abbexa
reference
abx269638
tested applications
P-ELISA
Description
Myeloid Differentiation Primary Response Protein MyD88 (MYD88) Peptide is a synthetic peptide.
Documents del producto
Instrucciones
Data sheet
Product specifications
| Category | Proteins and Peptides |
| Immunogen Target | Myeloid Differentiation Primary Response Protein MyD88 (MYD88) |
| Host | Synthetic |
| Recommended Dilution | BL (predicted): 0.5 mg/ml. Optimal dilutions/concentrations should be determined by the end user. |
| Conjugation | Unconjugated |
| Observed MW | Sequence Fragment: Internal region: C-IKYKAMKKEFP |
| Size 1 | 100 µg |
| Form | Lyophilized Reconstitute in deionized water. |
| Tested Applications | P-ELISA |
| Buffer | Prior to lyophilization: Deionized water. |
| Availability | Shipped within 5-10 working days. |
| Storage | Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles. |
| Dry Ice | No |
| Gene ID | 4615, 17874, 301059 |
| NCBI Accession | NP_001166038.2, NP_002459.3, NP_001166039.2, NP_001361717.1 |
| Alias | MYD88D,MYD88 innate immune signal transduction adaptor, IMD68 |
| Background | Protein MYD88 |
| Note | This product is for research use only. Not for human consumption, cosmetic, therapeutic or diagnostic use. |
Descripción
Related Products
Human MYD88 (Myeloid differentiation primary response protein MyD88) ELISA Kit
Ver Producto
MYD88 antibody
This gene encodes a cytosolic adapter protein that plays a central role in the innate and adaptive immune response. This protein functions as an essential signal transducer in the interleukin-1 and Toll-like receptor signaling pathways. These pathways regulate that activation of numerous proinflammatory genes. The encoded protein consists of an N-terminal death domain and a C-terminal Toll-interleukin1 receptor domain. Patients with defects in this gene have an increased susceptibility to pyogenic bacterial infections. Alternate splicing results in multiple transcript variants.
Ver Producto